Amitriptyline Hcl
Rank #376 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$25.8M
Total Cost
1,295,043
Total Claims
$25.8M
Total Cost
45,629
Prescribers
$20
Cost per Claim
133,728
Beneficiaries
2,327,890
30-Day Fills
$565
Avg Cost/Provider
28
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$25.8M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $25.8M total
Top Prescribers of Amitriptyline Hcl
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Fernando Gonzales-Portillo | Internal Medicine | Orlando, FL | 1,472 | $28K |
| 2 | Maritza Ortiz Acosta | Psychiatry | Ponce, PR | 1,097 | $23K |
| 3 | Juan Rodriguez | Rheumatology | Bayamon, PR | 943 | $19K |
| 4 | Millan Garcia | Psychiatry & Neurology | Arecibo, PR | 1,493 | $18K |
| 5 | Miljan Rosado Santiago | Psychiatry & Neurology | Aguadilla, PR | 673 | $15K |
| 6 | Barry Vaught | Neurology | Crab Orchard, WV | 693 | $13K |
| 7 | Zaleskie Ruiz | Psychiatry & Neurology | Cabo Rojo, PR | 960 | $13K |
| 8 | Jorge De Jesus | Psychiatry & Neurology | Mayaguez, PR | 879 | $13K |
| 9 | Melinda Aquino | Anesthesiology | Bronx, NY | 133 | $12K |
| 10 | Cesar Padilla | Licensed Professional Counselor | Camuy, PR | 660 | $12K |
| 11 | Purnima Thakran | Neurology | Apple Valley, CA | 319 | $12K |
| 12 | Daniel Hodges | Physical Medicine and Rehabilitation | Lafayette, LA | 695 | $11K |
| 13 | Gulshan Oberoi | Neurology | Laurel, MS | 298 | $11K |
| 14 | Rajbir Minhas | Internal Medicine | Cincinnati, OH | 633 | $9,913 |
| 15 | Vicotr Mariano Mercedes | Family Practice | Vega Baja, PR | 387 | $9,631 |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 373 | Chlorpromazine Hcl (Chlorpromazine Hcl) | $25.9M | 78,710 |
| 374 | Perampanel (Fycompa) | $25.9M | 20,876 |
| 375 | Timolol Maleate (Timolol Maleate) | $25.8M | 1,129,537 |
| 376 | Amitriptyline Hcl (Amitriptyline Hcl) | $25.8M | 1,295,043 |
| 377 | Tezepelumab-Ekko (Tezspire) | $25.6M | 5,900 |
| 378 | Ponatinib Hcl (Iclusig) | $25.6M | 1,209 |
| 379 | Citalopram Hydrobromide (Citalopram Hbr) | $25.3M | 2,778,255 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology